Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-02-12 Sale | 2021-02-17 8:39 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 2,216,798 | $65 | $144,091,870 | 10,084,938 (Indirect) | View |
2020-12-11 Sale | 2020-12-15 4:47 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 64,624 | $80.14 | $5,179,285 | 12,585,045 (Indirect) | View |
2020-08-12 Sale | 2020-08-14 4:50 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,443,247 | $31.65 | $45,678,768 | 12,649,669 (Indirect) | View |
2020-06-26 Sale | 2020-06-30 7:17 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 250,000 | $23.97 | $5,993,052 | 14,092,916 (Indirect) | View |
2020-06-19 Sale | 2020-06-23 5:41 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K Neuro Line Partners LP Bratton Capital Management L.P. Bratton Capital Inc. 10% Owner | 255,000 | $24.72 | $6,304,373 | 14,342,916 (Indirect) | View |
2020-06-05 Sale | 2020-06-09 4:10 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 1,922,855 | $25.75 | $49,513,516 | 14,597,916 (Indirect) | View |
2020-02-26 Sale | 2020-02-28 4:25 pm | Denali Therapeutics Inc. | DNLI | BRATTON DOUGLAS K AKDL L.P. Crestline SI (GP) L.P. Crestline Investors Inc. Crestline Management LP 10% Owner | 3,894,764 | $20.25 | $78,868,971 | 16,520,771 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion